The Spatial Technologies Unit (STU) at BIDMC is a production-grade facility supporting HCC investigators in cutting-edge spatial tissue profiling and single-cell studies—often from the same tissue block. The STU operates across a wide range of projects, including basic science, translational research, clinical trials (correlative and endpoint studies), and industry-sponsored investigations. It also serves as a core facility for programmatic grants (e.g., U54, P01).
Established with a four-part mandate, the STU:
- Provides full-service support (from tissue to complete data analysis) using the latest spatial transcriptomic and proteomic technologies
- Offers hands-on training and education in experimental design, grant writing, and data analysis
- Develops and pilots new spatial assays and technologies
- Enables spatial tissue profiling assays to reach patient care

